Apexigen Inc
Change company Symbol lookup
Select an option...
APGN Apexigen Inc
NSRGY Nestle SA
WE WeWork Inc
NOK Nokia Oyj
HLNE Hamilton Lane Inc
SAL Salisbury Bancorp Inc
MFON Mobivity Holdings Corp
XPEV Xpeng Inc
ENVX Enovix Corp
COGT Cogent Biosciences Inc
Go

Company profile

Apexigen, Inc., formerly Brookline Capital Acquisition Corp., is a clinical-stage biopharmaceutical company. The Company is focused on developing antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. It has a diversified pipeline of wholly owned and partnered assets leveraging its APXiMAB antibody discovery platform. The Company’s pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in Phase II clinical development, and also includes several preclinical stage immuno-oncology programs. The Company’s lead asset, sotigalimab, is a CD40 agonist with epitope specificity and Fc receptor engagement for optimal therapeutic effect. Its sotigalimab is used for the treatment of Melanoma (post PD-1), Esophageal/GEJ, Sarcoma, Rectal and Ovarian cancers. Its pipeline also includes APX601 and APX801. It has out-licensed five programs for the development of product candidates that were discovered using the APXiMAB platform.

Premarket

Last Trade
Delayed
$7.09
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$7.09
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
329

10-day average volume:
414,042
329

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VMW, GBRG, COVA

2:55 pm ET May 26, 2022 (PR Newswire) Print

Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

https://mma.prnewswire.com/media/1553538/Firm_Logo_with_Investor_Law_Firm.jpg

VMware, Inc. (NYSE: VMW)'s sale to Broadcom Inc. Under the terms of the merger, VMware shareholders may elect to receive either $142.50 in cash or 0.2520 shares of Broadcom common stock for each share of VMware they own. The shareholder election is subject to proration. If you are a VMware shareholder, click here to learn more about your rights and options.

Goldenbridge Acquisition Limited (NASDAQ: GBRG)'s merger with Auto Services Group Limited. If you are a Goldenbridge shareholder, click here to learn more about your rights and options.

COVA Acquisition Corp. (NASDAQ: COVA)'s merger with ECARX Holdings, Inc. If you are a COVA shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com

https://c212.net/c/img/favicon.png?sn=NY70773&sd=2022-05-26

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-notice-halper-sadeh-llp-investigates-vmw-gbrg-cova-301556028.html

SOURCE Halper Sadeh LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=NY70773&Transmission_Id=202205261455PR_NEWS_USPR_____NY70773&DateId=20220526

comtex tracking

COMTEX_407811235/1005/2022-05-26T14:55:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.